At Italy’s leading science communication event, VPH introduced its In Silico Medicine Info Kit, a resource designed to support researchers in engaging more effectively with patients, clinicians, policymakers and society.
Elevate your institution’s profile by organising our biannual international conference, the flagship event of the in silico medicine community.
A list of interesting initiatives of relevance for the in silico medicine community.
For two days, the EPF Congress united Europe’s leading voices from across the healthcare ecosystem to engage in essential conversations about the future of patient involvement.
This pilot will allow sponsors to submit a single application for pilot coordinated assessments, assuring more harmonised interaction with the Member States approving the clinical investigation or performance studies.
On 5 November 2025, our Director, Prof. Liesbet Geris, attended the MDIC Computational Modeling & Simulation Symposium in College Park, MD, a key gathering for advancing the use of computer modelling & simulation (CM&S) and accelerating medical innovation.
Over the past decade, we laid the foundation for a global movement in in silico medicine, building the community, advancing science, engaging regulators, and shaping policy. Today, as the field grows in scale and impact, so do we.
Discover the recently published papers from our community!
STEP4NAMs invites SMEs, companies and research institutions to take part in its pilot studies on NAMs validation.
The VPH is entering a new phase in its evolution as the International Scientific Society for In Silico Medicine.
The European Partnership for Personalised Medicine, EP PerMed, publishes a funding call for Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases (CARMEN2026)
